In 2017, Arterys's cardiac MRI technology, which examines the heart and blood flow through its ventricles, became the first cloud - based AI platform to be FDA - approved for
use in clinical settings.
«ImPACT Pediatric is an iPad - based computerized test that is individually administered, engaging for children, and easy to
use in a clinical setting.
The team developed the all - optical ultrasound imaging technology for
use in a clinical setting over four years.
It also reduces anxiety and confusion in people with dementia, improving their quality of life, and is beneficial psychologically and physiologically when
used in clinical settings.
In the paper, Case and colleagues suggest that, based on the results, nanoparticles
used in a clinical setting might need to be evaluated for such unforeseen effects.
The results point to the need to fully understand how this treatment could be
used in clinical settings.
The team has developed and built specialized equipment that can be
used in a clinical setting to measure changes in oxygen saturation to diagnose and monitor glaucoma more effectively.
The team will continue to develop and test an imaging - based biomarker that can be
used in a clinical setting to enable us to understand the molecular changes to the ganglion cells, so we can detect the disease very early on.
Genome sequencing will be increasingly
used in the clinical setting to tailor antimicrobial prescribing and inform infection control outbreaks.
No, probably not, because VO2 max is a measure that's often
used in a clinical setting and seldom used out «in the real world».
Knowledge statement questions are focused on areas of knowledge that a vet tech must know and can range from direct veterinary questions to questions focusing on the correct medical record keeping techniques a vet tech will
use in a clinical setting.
They are clearly the most effective treatment for this disorder, although potentially debilitating side effects limit
their use in this clinical setting.
Such discrepancies may have occurred because these measures are more often
used in clinical settings rather than in research settings and, therefore, have received little attention in the pediatric psychology research literature.
Although video feedback is usually delivered in the home environment, it has also been
used in clinical settings such as, for example, hospital environments with mothers of preterm babies (Hoffenkamp 2015), and residential treatment centres (Kennedy 2010).
Its ease of administration, and the information it provides, should recommend it for wider
use in clinical settings.
However, we note that over 130 studies have used self - report measures of CU or psychopathic traits such as the ICU (Frick et al. 2014) and there is still no consensus whether parents, teachers or the young people themselves are better informants about the presence or absence of CU traits and the guidance in the DSM - 5 is that information from all three sources can be
used in clinical settings (American Psychiatric Association 2013).
Not exact matches
While the researchers hope to
use these findings
in a
clinical setting, they also seem to offer ready - made advice for those suffering from everyday levels of shyness.
In recent years, Levine and others have used clinical studies to prove that even in healthy people, a chair - based lifestyle sets up the physiological conditions for the onset of Type 2 diabetes, cardiovascular disease, obesity — and ultimately, shorter lifespan
In recent years, Levine and others have
used clinical studies to prove that even
in healthy people, a chair - based lifestyle sets up the physiological conditions for the onset of Type 2 diabetes, cardiovascular disease, obesity — and ultimately, shorter lifespan
in healthy people, a chair - based lifestyle
sets up the physiological conditions for the onset of Type 2 diabetes, cardiovascular disease, obesity — and ultimately, shorter lifespans.
After much research on the Ketogenic Diet, I fine tuned my knowledge of it under the tutelage of the amazing folks at the Charlie Foundation, a non-profit that promotes the
use of the Ketogenic Diet
in the
clinical setting as a non-pharmacological treatment for epilepsy.
Now a department chairman at Mercy Hospital
in Pittsburgh, he
set up the first
clinical bone bank
in the nation, pioneered work
in new types of ear operations and founded a clinic for deaf children,
using his own funds to start it.
This is an incredibly difficult question to answer for a variety of reasons, most importantly because over the years our once vaunted «beautiful» style of play has become a shadow of it's former self, only to be replaced by a less than stellar «plug and play» mentality where players play out of position and adjustments / substitutions are rarely forthcoming before the 75th minute... if you look at our current players, very few would make sense
in the traditional Wengerian system... at present, we don't have the personnel to move the ball quickly from deep - lying position, efficient one touch midfielders that can make the necessary through balls or the disciplined and pacey forwards to stretch defences into wide positions, without the aid of the backs coming up into the final 3rd, so that we can attack the defensive lanes
in the same
clinical fashion we did years ago... on this current squad, we have only 1 central defender on staf, Mustafi, who seems to have any prowess
in the offensive zone or who can even pass two zones through so that we can advance play quickly out of our own end (I have seen some inklings that suggest Holding might have some offensive qualities but too early to tell)... unfortunately Mustafi has a tendency to get himself
in trouble when he gets overly aggressive on the ball... from our backs out wide, we've seen pace from the likes of Bellerin and Gibbs and the spirited albeit offensively stunted play of Monreal, but none of these players possess the skill -
set required
in the offensive zone for the new Wenger scheme which requires deft touches, timely runs to the baseline and consistent crossing, especially when Giroud was playing and his ratio of scored goals per clear chances was relatively low (better last year though)... obviously I like Bellerin's future prospects, as you can't teach pace, but I do worry that he regressed last season, which was obvious to Wenger because there was no way he would have
used Ox as the right side wing - back so often knowing that Barcelona could come calling
in the off - season, if he thought otherwise... as for our midfielders, not a single one, minus the more confident Xhaka I watched played for the Swiss national team a couple years ago, who truly makes sense under the traditional Wenger model... Ramsey holds onto the ball too long, gives the ball away cheaply far too often and abandons his defensive responsibilities on a regular basis (doesn't score enough recently to justify): that being said, I've always thought he does possess a little something special, unfortunately he thinks so too... Xhaka is a little too slow to ever boss the midfield and he tends to telegraph his one true strength, his long ball play: although I must admit he did get a bit better during some points
in the latter part of last season... it always made me wonder why whenever he played with Coq Wenger always seemed to play Francis
in a more advanced role on the pitch... as for Coq, he is way too reckless at the wrong times and has exhibited little offensive prowess yet finds himself
in and around the box far too often... let's face it Wenger was ready to throw him
in the trash heap when injuries forced him to
use Francis and then he had the nerve to act like this was all part of a bigger Wenger constructed plan... he like Ramsey, Xhaka and Elneny don't offer the skills necessary to satisfy the quick transitory nature of our old offensive scheme or the stout defensive mindset needed to protect the defensive zone so that our offensive players can remain aggressive
in the final third... on the front end, we have Ozil, a player of immense skill but stunted by his physical demeanor that tends to offend, the fact that he's been played out of position far too many times since arriving and that the players
in front of him, minus Sanchez, make little to no sense considering what he has to offer (especially Giroud); just think about the quick counter-attack offence
in Real or the space and protection he receives
in the German National team's midfield, where teams couldn't afford to focus too heavily on one individual... this player was a passing «specialist» long before he arrived
in North London, so only an arrogant or ignorant individual would try to reinvent the wheel and / or not surround such a talent with the necessary components...
in regards to Ox, Walcott and Welbeck, although they all possess serious talents I see them
in large part as headless chickens who are on the injury table too much, lack the necessary first - touch and / or lack the finishing flair to warrant their inclusion
in a regular starting eleven; I would say that, of the 3, Ox showed the most upside once we went to a back 3, but even he became a bit too consumed by his pending contract talks before the season ended and that concerned me a bit... if I had to choose one of those 3 players to stay on it would be Ox due to his potential as a plausible alternative to Bellerin
in that wing - back position should we continue to
use that formation...
in Sanchez, we get one of the most committed skill players we've seen on this squad for some years but that could all change soon, if it hasn't already of course... strangely enough, even he doesn't make sense given the constructs of the original Wenger offensive model because he holds onto the ball too long and he will give the ball up a little too often
in the offensive zone... a fact that is largely forgotten due to his infectious energy and the fact that the numbers he has achieved seem to justify the means... finally, and
in many ways most crucially, Giroud, there is nothing about this team or the offensive system that Wenger has traditionally employed that would even suggest such a player would make sense as a starter... too slow, too inefficient and way too easily dispossessed... once again, I think he has some special skills and, at times, has showed some world - class qualities but he's lack of mobility is an albatross around the necks of our offence... so when you ask who would be our best starting 11, I don't have a clue because of the 5 or 6 players that truly deserve a place
in this side, 1 just arrived, 3 aren't under contract beyond 2018 and the other was just sold to Juve... man, this is theraputic because following this team is like an addiction to heroin without the benefits
Despite finding that underreporting continues to be what she wrote
in two 2013 studies to be an «alarming» [17] and «overwhelming» problem, [16] Johna Register - Mihalik, Ph.D, LAT, ATC, Senior Research Associate at WakeMed and Adjunct Assistant Professor at UNC - Chapel Hill, told MomsTEAM that the the reason the
use of impact sensors was not among the recommendations she and her co-authors
in those studies made to address the problem of chronic underreporting was that she viewed «the
use of impact sensors
in concussion detection, as the science, although a growing field of information, is just not quite there
in how these may best be
used from a
clinical standpoint and across all sport
settings.»
Despite finding that underreporting continues to be what she wrote
in two 2013 studies to be an «alarming» and «overwhelming» problem, Dr. Johna Register - Mihalik, a research scientist and member of the faculty at the Matthew Gfeller Sport - Related TBI Research Center at the University of North Carolina at Chapel Hill, recently told MomsTEAM that the reason she and her colleagues did not recommend the
use of impact sensors
in addressing the problem was that she viewed «the
use of impact sensors
in concussion detection, as the science, although a growing field of information, [as] just not quite there
in [terms of] how the [y] may best be
used from a
clinical standpoint and across all sport
settings.»
Resident behaviors
in the
clinical setting were measured before and after the intervention
using telephone surveys of breastfeeding mothers after a clinic visit with a pediatric resident.
Similar drugs are
used clinically as antidepressants, the authors write, and their effects on tumors
in clinical settings are being investigated.
To succeed as a clinician - researcher, a physician - scientist
uses his or her mastery of both
clinical practice and basic science research
in parallel, often drawing on both skill
sets to find advances
in the diagnosis, treatment, and prevention of human disease.
This is the first study of a life - sustaining treatment form
using the Long - Term Care Minimum Data
Set, or MDS, a federally mandated
clinical assessment of all residents
in nursing homes certified by Medicare or Medicaid.
This is meant to be
used by anesthesiologists
in a
clinical setting.
«With additional validation, this test has potential for
use in clinical and agricultural
settings.»
Rather than a
set of hard - and - fast rules, the guideline is intended as an aid to
clinical decision making for professionals at all levels of experience
in treating opioid
use disorders.
Published
in Clinical Infectious Diseases and now available online, the findings suggest more efforts are needed to educate clinicians about the appropriate
use of antivirals and antibiotics
in the outpatient
setting.
In a review published online today in JAMA Oncology, the Penn team says finding a way to use these techniques more widely in clinical settings should be a top priorit
In a review published online today
in JAMA Oncology, the Penn team says finding a way to use these techniques more widely in clinical settings should be a top priorit
in JAMA Oncology, the Penn team says finding a way to
use these techniques more widely
in clinical settings should be a top priorit
in clinical settings should be a top priority.
It won't be more widely
used until we have the technology to analyze a microbiome precisely
in a
clinical setting, and until that planned double - blind study takes place.
As their novel technique for drug delivery is non-invasive and easy to
use, the NUS team envisioned that the microneedles patch has great potential for applications
in clinical and home care
settings for the management of perioperative pain and chronic pain
in patients suffering from conditions like diabetes and cancer.
Kelly E. Dunn, Ph.D., of the Johns Hopkins University School of Medicine, Baltimore, and coauthors conducted a randomized
clinical trial
in a residential research
setting with 103 patients, mostly men, with opioid
use disorder.
«We
set out on a mission to show if you treat patients with the doses that were
used in the
clinical trials, they will do better.
«Although hypothermia is a promising strategy to improve resuscitation and brain recovery following cardiac arrest, the results of the current study do not support routine
use of cold intravenous fluid
in the prehospital
setting to improve
clinical outcomes,» the authors write.
«The number of new diagnostic and prognostic tools for dementia is steadily increasing and there are a lot of different scanning techniques currently being
used in clinical research
settings.
«Once we've shown that this can safely be
used in human patients with pulmonary hypertension — and we've got a
clinical trial
in progress right now — we'll be able to conduct studies of inhaled NO delivered
in ambulatory
settings, including patients» homes, to treat chronic pulmonary hypertension, right - sided heart failure and chronic obstructive pulmonary disease.»
The research team had subjects complete a
set of tasks commonly
used in similar
clinical trials.
The researchers
set out to see whether the effect of
using IMRT
in those patients who would have received a dose greater than 107 % to parts of their breast with 2DRT would translate into
clinical benefit.
The white paper recommends that practitioners follow relevant guidance documents and that deviation from consensus recommendations should be supported by
clinical studies or pursued
in the
setting of a
clinical trial approved by an institutional review board; that practitioners receive training
in a new procedure before beginning its practice, that the training should include a practical, «hands - on» component and that all team members directly involved with the radiation therapy decisions should participate
in at least five proctored cases before performing similar procedures independently; and that professional societies should accelerate the generation of new or updated guidance documents for the following disease sites and techniques: skin, central nervous system, gastrointestinal, lung or endobronchial and esophagus, and, while outside the charge of this panel, assess the need for updated guidance documents for accelerated partial breast irradiation
using electronic brachytherapy.
Ciara Reilly, Chief Executive of Every Day Harmony, the music therapy charity that was a partner
in the research, said: «Music therapy has often been
used with children and young people with particular mental health needs, but this is the first time its effectiveness has been shown by a definitive randomised controlled trail
in a
clinical setting.
«
In the
clinical setting, patients have complained that their headaches became worse after
using regular codeine, not better,» Professor Rolan says.
The researchers hope these findings will elicit a sense of caution
in future HIV
clinical trials
set out to
use antibodies for prevention, especially
in the mother - to - child
setting.
Goodwin advises that additional attention to cannabis
use in tobacco control efforts and
in clinical settings aimed at reducing cigarette smoking and smoking related negative consequences may be warranted.
«If PancreaSeq is going to be
used to make
clinical decisions, then it needed to be evaluated
in a
clinical setting in real time, with all the pressures that go with a
clinical diagnosis.»
In the consensus statement endorsed by the American Academy of Pediatrics and published in the December Journal of the Academy of Nutrition and Dietetics, and Nutrition in Clinical Practice, the two organizations say: «The universal use of a single set of diagnostic parameters will expedite the recognition of pediatric undernutrition, lead to the development of more accurate estimates of its prevalence and incidence, direct interventions and promote improved outcomes.&raqu
In the consensus statement endorsed by the American Academy of Pediatrics and published
in the December Journal of the Academy of Nutrition and Dietetics, and Nutrition in Clinical Practice, the two organizations say: «The universal use of a single set of diagnostic parameters will expedite the recognition of pediatric undernutrition, lead to the development of more accurate estimates of its prevalence and incidence, direct interventions and promote improved outcomes.&raqu
in the December Journal of the Academy of Nutrition and Dietetics, and Nutrition
in Clinical Practice, the two organizations say: «The universal use of a single set of diagnostic parameters will expedite the recognition of pediatric undernutrition, lead to the development of more accurate estimates of its prevalence and incidence, direct interventions and promote improved outcomes.&raqu
in Clinical Practice, the two organizations say: «The universal
use of a single
set of diagnostic parameters will expedite the recognition of pediatric undernutrition, lead to the development of more accurate estimates of its prevalence and incidence, direct interventions and promote improved outcomes.»
The Academy and ASPEN recommend that «a standardized
set of diagnostic indicators be
used to identify and document pediatric malnutrition (undernutrition)
in routine
clinical practice.»
The working group included five practicing hospitalists with expertise
in opioid
use in the hospital
setting and involvement
in clinical research related to opioid
use and outcomes
in hospitalized patients.